【4554】富士製薬工業

ジェネリック医薬品。大株主に三井物産。

東証プライム

医薬品医薬

＞

ジェネリックメーカージェ

業績予想修正履歴

{{models[key].tabname}}

決算期	日付	予・実	売上高 (百万円)	対前回	修正率	修正率	営業利益 (百万円)	対前回	修正率	修正率	経常利益 (百万円)	対前回	修正率	修正率	当期利益 (百万円)	対前回	修正率	修正率
2024.09	2024/02/08	Q1予	48,926	→	0.0%	0.0%	4,907	→	0.0%	0.0%	5,562	→	0.0%	0.0%	6,185	→	0.0%	+54.0%
2024.09	2023/11/27	修正予	48,926	→	0.0%	0.0%	4,907	→	0.0%	0.0%	5,562	→	0.0%	0.0%	6,185	↑	+54.0%	+54.0%
2024.09	2023/11/09	当初予	48,926	-	-	-	4,907	-	-	-	5,562	-	-	-	4,015	-	-	-
2023.09	2023/11/09	実	40,889	↓	-5.6%	-5.6%	3,858	↓	-4.7%	-4.7%	4,519	↑	+10.5%	+10.5%	3,435	↑	+15.5%	+15.5%
2023.09	2023/08/08	Q3予	43,311	→	0.0%	0.0%	4,048	→	0.0%	0.0%	4,088	→	0.0%	0.0%	2,974	→	0.0%	0.0%
2023.09	2023/05/11	Q2予	43,311	→	0.0%	0.0%	4,048	→	0.0%	0.0%	4,088	→	0.0%	0.0%	2,974	→	0.0%	0.0%
2023.09	2023/02/09	Q1予	43,311	→	0.0%	0.0%	4,048	→	0.0%	0.0%	4,088	→	0.0%	0.0%	2,974	→	0.0%	0.0%
2023.09	2022/11/10	当初予	43,311	-	-	-	4,048	-	-	-	4,088	-	-	-	2,974	-	-	-
2022.09	2022/11/10	実	35,426	→	0.0%	-1.5%	3,777	→	0.0%	+8.2%	3,725	→	0.0%	+5.2%	2,696	↓	-3.3%	+5.2%
2022.09	2022/11/02	修正予	35,426	↓	-1.5%	-1.5%	3,777	↑	+8.2%	+8.2%	3,725	↑	+5.2%	+5.2%	2,787	↑	+8.8%	+8.8%
2022.09	2022/08/05	Q3予	35,966	→	0.0%	0.0%	3,490	→	0.0%	0.0%	3,540	→	0.0%	0.0%	2,562	→	0.0%	0.0%
2022.09	2022/05/06	Q2予	35,966	→	0.0%	0.0%	3,490	→	0.0%	0.0%	3,540	→	0.0%	0.0%	2,562	→	0.0%	0.0%
2022.09	2022/02/04	Q1予	35,966	→	0.0%	0.0%	3,490	→	0.0%	0.0%	3,540	→	0.0%	0.0%	2,562	→	0.0%	0.0%
2022.09	2021/11/05	当初予	35,966	-	-	-	3,490	-	-	-	3,540	-	-	-	2,562	-	-	-
2021.09	2021/11/05	実	33,990	↓	-2.1%	-2.1%	3,349	↑	+17.2%	+17.2%	3,250	↑	+15.8%	+15.8%	2,432	↑	+15.8%	+15.8%
2021.09	2021/08/05	Q3予	34,702	→	0.0%	0.0%	2,857	→	0.0%	0.0%	2,807	→	0.0%	0.0%	2,100	→	0.0%	0.0%
2021.09	2021/02/04	Q1予	34,702	→	0.0%	0.0%	2,857	→	0.0%	0.0%	2,807	→	0.0%	0.0%	2,100	→	0.0%	0.0%
2021.09	2020/11/05	当初予	34,702	-	-	-	2,857	-	-	-	2,807	-	-	-	2,100	-	-	-
2020.09	2020/11/05	実	33,793	↓	-0.1%	-0.1%	3,139	↑	+22.1%	+22.1%	2,983	↑	+19.3%	+19.3%	2,085	↑	+25.3%	+25.3%
2020.09	2020/08/06	Q3予	33,830	→	0.0%	0.0%	2,571	→	0.0%	0.0%	2,501	→	0.0%	0.0%	1,664	→	0.0%	0.0%
2020.09	2020/07/01	修正予	33,830	→	0.0%	0.0%	2,571	→	0.0%	0.0%	2,501	→	0.0%	0.0%	1,664	↑	+238.2%	0.0%
2020.09	2020/05/08	修正予	33,830	→	0.0%	0.0%	2,571	→	0.0%	0.0%	2,501	→	0.0%	0.0%	492	↓	-70.4%	-70.4%
2020.09	2020/02/06	Q1予	33,830	→	0.0%	0.0%	2,571	→	0.0%	0.0%	2,501	→	0.0%	0.0%	1,664	→	0.0%	0.0%
2020.09	2019/11/08	当初予	33,830	-	-	-	2,571	-	-	-	2,501	-	-	-	1,664	-	-	-
2019.09	2019/11/08	実	36,279	↓	-1.5%	-1.5%	4,173	↓	-8.0%	-8.0%	4,169	↓	-7.5%	-7.5%	2,962	↓	-12.8%	-12.8%
2019.09	2019/08/08	Q3予	36,815	→	0.0%	0.0%	4,535	→	0.0%	0.0%	4,506	→	0.0%	0.0%	3,396	→	0.0%	0.0%
2019.09	2019/05/09	Q2予	36,815	→	0.0%	0.0%	4,535	→	0.0%	0.0%	4,506	→	0.0%	0.0%	3,396	→	0.0%	0.0%
2019.09	2019/02/07	Q1予	36,815	→	0.0%	0.0%	4,535	→	0.0%	0.0%	4,506	→	0.0%	0.0%	3,396	→	0.0%	0.0%
2019.09	2018/11/09	当初予	36,815	-	-	-	4,535	-	-	-	4,506	-	-	-	3,396	-	-	-
2018.09	2018/11/09	実	37,909	↓	-0.6%	-0.6%	4,391	↓	-9.5%	-9.5%	4,472	↓	-5.1%	-5.1%	3,372	↑	+0.8%	+0.8%
2018.09	2018/08/09	Q3予	38,139	→	0.0%	0.0%	4,850	→	0.0%	0.0%	4,710	→	0.0%	0.0%	3,345	→	0.0%	0.0%
2018.09	2018/05/10	Q2予	38,139	→	0.0%	0.0%	-	-	-	-	4,710	→	0.0%	0.0%	3,345	→	0.0%	0.0%
2018.09	2018/02/08	Q1予	38,139	→	0.0%	0.0%	4,850	→	0.0%	0.0%	4,710	→	0.0%	0.0%	3,345	→	0.0%	0.0%
2018.09	2017/11/10	当初予	38,139	-	-	-	4,850	-	-	-	4,710	-	-	-	3,345	-	-	-
2017.09	2017/11/10	実	35,387	↓	-2.5%	-2.5%	4,314	↑	+0.3%	+0.3%	4,628	↑	+10.7%	+10.7%	3,301	↑	+17.9%	+17.9%
2017.09	2017/08/08	Q3予	36,300	→	0.0%	0.0%	4,300	→	0.0%	0.0%	4,180	→	0.0%	0.0%	2,800	→	0.0%	0.0%
2017.09	2017/05/10	Q2予	36,300	→	0.0%	0.0%	4,300	→	0.0%	0.0%	4,180	→	0.0%	0.0%	2,800	→	0.0%	0.0%
2017.09	2017/02/08	Q1予	36,300	→	0.0%	0.0%	4,300	→	0.0%	0.0%	4,180	→	0.0%	0.0%	2,800	→	0.0%	0.0%
2017.09	2016/11/11	当初予	36,300	-	-	-	4,300	-	-	-	4,180	-	-	-	2,800	-	-	-
2016.09	2016/11/11	実	34,229	↓	-0.7%	-0.7%	3,568	↑	+2.5%	+2.5%	3,251	↓	-5.2%	-5.2%	2,118	↓	-5.0%	-5.0%
2016.09	2016/08/09	Q3予	34,470	→	0.0%	0.0%	3,480	→	0.0%	0.0%	3,430	→	0.0%	0.0%	2,230	→	0.0%	0.0%
2016.09	2016/05/12	Q2予	34,470	→	0.0%	0.0%	3,480	→	0.0%	0.0%	3,430	→	0.0%	0.0%	2,230	→	0.0%	0.0%
2016.09	2016/02/09	Q1予	34,470	→	0.0%	0.0%	3,480	→	0.0%	0.0%	3,430	→	0.0%	0.0%	2,230	→	0.0%	0.0%
2016.09	2015/11/13	当初予	34,470	-	-	-	3,480	-	-	-	3,430	-	-	-	2,230	-	-	-
2015.09	2015/11/13	実	31,680	↓	-1.1%	-1.1%	3,251	↓	-9.4%	-9.4%	3,099	↓	-12.9%	-12.9%	2,092	↓	-7.4%	-7.4%
2015.09	2015/08/07	Q3予	32,030	→	0.0%	0.0%	3,590	→	0.0%	0.0%	3,560	→	0.0%	0.0%	2,260	→	0.0%	0.0%
2015.09	2015/05/13	Q2予	32,030	→	0.0%	0.0%	3,590	→	0.0%	0.0%	3,560	→	0.0%	0.0%	2,260	→	0.0%	0.0%
2015.09	2015/02/10	Q1予	32,030	→	0.0%	0.0%	3,590	→	0.0%	0.0%	3,560	→	0.0%	0.0%	2,260	→	0.0%	0.0%
2015.09	2014/11/14	当初予	32,030	-	-	-	3,590	-	-	-	3,560	-	-	-	2,260	-	-	-
2014.09	2014/11/14	実	29,215	-	-	-	3,173	-	-	-	3,198	-	-	-	2,078	-	-	-

【4554】富士製薬工業 ジェネリック医薬品。大株主に三井物産。

業績予想修正履歴

【4554】富士製薬工業

ジェネリック医薬品。大株主に三井物産。